Repository logo
 

Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations.


Loading...
Thumbnail Image

Change log

Abstract

Recent discoveries of somatic mutations permit the recognition of subtypes of aldosterone-producing adenomas with distinct clinical presentations and pathological features. Here we describe three women with hyperaldosteronism, two who presented in pregnancy and one who presented after menopause. Their aldosterone-producing adenomas harbored activating mutations of CTNNB1, encoding β-catenin in the Wnt cell-differentiation pathway, and expressed LHCGR and GNRHR, encoding gonadal receptors, at levels that were more than 100 times as high as the levels in other aldosterone-producing adenomas. The mutations stimulate Wnt activation and cause adrenocortical cells to de-differentiate toward their common adrenal-gonadal precursor cell type. (Funded by grants from the National Institute for Health Research Cambridge Biomedical Research Centre and others.).

Description

This is a metadata record relating to an article that cannot be shared due to publisher copyright.

Journal Title

N Engl J Med

Conference Name

Journal ISSN

0028-4793
1533-4406

Volume Title

373

Publisher

Massachusetts Medical Society

Rights and licensing

Except where otherwised noted, this item's license is described as All rights reserved
Sponsorship
Wellcome Trust (085686/Z/08/A)
British Heart Foundation (None)
British Heart Foundation (None)
MRC (MR/K501050/1)
Wellcome Trust (100140/Z/12/Z)
British Heart Foundation (None)
British Heart Foundation (None)
British Heart Foundation (None)
AEDT is supported by Agency for Science, Technology and Research (A*STAR) Singapore and the Wellcome Trust (085686/Z/08/A); SG and LHS are supported by the British Heart Foundation (FS/14/75/31134; FS/11/35/28871); EABA was supported by the Tunku Abdul Rahman Centenary Fund (St Catharine's College, Cambridge, UK) and the Austin Doyle Award (Servier Australia). JZ was supported by the Cambridge Overseas Trust Scholarship. MG is supported by the NIHR Cambridge Biomedical Research Centre (Metabolic), and MB is supported by the MRC (U105192713). The work was funded by the NIHR Cambridge Biomedical Research Centre (Cardiovascular) and an NIHR Senior Investigator award (NF-SI-0512-10052) to MJB.